Measles, Mumps, Rubella and Varicella virus vaccine live (Merck Sharp & Dohme)

麻疹、腮腺炎、风疹、水痘减毒活疫苗（默沙东）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMeasles, Mumps, Rubella and Varicella virus vaccine live (Merck Sharp & Dohme)
Drug Alias NameProQuad
ClassificationVaccines > Biological material > Toxoid vaccineVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRejection of renal transplantationHeart DiseasesRenal Insufficiency, Chronic +[11] 
Global Approved IndicationsRubellaMumpsMeasles +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2006/04/05
Country/TerritoryUnited StatesMexicoAustralia +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme Bv
Inactive CompaniesGlaxosmithkline PlcMedical University Of South CarolinaNational Institute Of Allergy And Infectious Diseases (Niaid) +[4] 
Active IndicationsRubellaMumpsMeasles +[4] 
Inactive IndicationsRejection of renal transplantationHeart DiseasesRenal Insufficiency, Chronic +[7] 

Other Information

ATC CodeJ07BD54
Related LinksN/A